Navigation Links
VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress

SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Rebecca A. Taub, MD, VIA's senior vice president of research and development, will present at the 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress taking place August 4-7 in Boston, MA.

The presentation details are as follows:

Date/Time: Wednesday, August 6, 2008: 2:20-2:50 p.m. ET

Location: World Trade Center Boston & Seaport Hotel

Session: Translational Medicine IV: Case Studies of Translational

Approaches from Preclinical to Clinical Proof-of-Concept

Title: Innovative Clinical Trial and Biomarker Approaches To Demonstrate

the Role Of Leukotrienes and 5LO Inhibition in Atherosclerotic Disease

"VIA has taken an innovative approach in its design of Phase 2 clinical trials for VIA-2291, its lead compound," said Dr. Taub. "I am excited to share with conference participants our view on the value of innovative techniques in the design of critical clinical trials, particularly with regards to serum inflammatory biomarkers, analyses of atherosclerotic plaque tissue, and non-invasive imaging."

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
2. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
3. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
4. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)
5. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
6. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
7. Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
8. Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
9. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
10. Poniard Pharmaceuticals Announces Upcoming Conference Participation
11. Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup uBiome today launched the ... relationship between weight management and the microbiome. The study uses the ResearchKit framework, designed ... iPhone app. , The uBiome app is available as a free download from the ...
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier ... that it has been selected by The Michael J. ... cell lines to academic, pharmaceutical, and biotechnology organizations committed ... the United States , and more ... the United States , and more ...
(Date:10/8/2015)... , Oct. 8, 2015 The 2015 Nobel ... The University of Texas at Dallas. Aziz Sancar , ... Dallas in 1977, is one of three ... cells continuously monitor and repair damaged DNA on a molecular level.  ... molecular and cell biology from UT Dallas ...
(Date:10/8/2015)... LOUIS , Oct. 8, 2015  Sigma-Aldrich ... the Cerilliant ® brand within its Applied ... new bile acid reference standards product line with ... most routinely tested bile acids and their stable-labeled ... (CRMs) consist of lithocholic acid, taurocholic acid and ...
Breaking Biology Technology:
... services, cell lines, and reagents now cover nearly half ... leading experts in ion channels and GPCR (G-protein coupled ... - are now united. ChanTest, the leading provider of ... that it has acquired Rockville, Maryland-based Applied Cell Sciences. ...
... Public Company, our most Important Asset is our Shareholders, ... Sheets: SYNJ), reports that on February 26th, 2009, the ... quarterly stock dividends, similar to the Dividend currently being ... growth potential, especially with the developments in our green ...
... February 26 ScreenCancer AS, a Norwegian,company ... insurance,companies and individuals, today announced that it ... screening test to its European Cancer,Screening Program. ... a subsidiary of Quest Diagnostics Incorporated (NYSE: ...
Cached Biology Technology:
(Date:9/10/2015)... , Sept. 10, 2015 Pursuant ... Clinic Wellness to create an interactive, image-based health ... health and wellness kiosk.  The unique assessment quantifies ... a number that suggests an individual,s biological age ... values as measured by the kiosk. ...
(Date:9/9/2015)... British Columbia , Sept. 9, 2015 /PRNewswire/ ... numerous organizational and solution-based milestones, furthering the company,s ... perils of online fraud. NuData Security,s ... in enhancing the company,s growth cycle. The product ... learning to determine good user behavior from fraudulent ...
(Date:9/8/2015)... 8, 2015  Affectiva, global leader in emotion-sensing ... Service, a new data solution, and version 2.0 ... Affectiva,s highly accurate and patented science, these new ... to transform industries such as market research, gaming, ... experience, online education, HR, automotive, robotics, healthcare and ...
Breaking Biology News(10 mins):
... Stockholm, Sweden Only by viewing a Seurat painting at ... small, distinct dots of pure color applied in patterns ... geneticists have long sought to analyze profiles of genes at ... a view from afar until now. Research published ...
... need to evaluate nature,s repository of chemicals in plants, ... health care will be a major theme of a ... to draw some 1,200 natural products researchers from around ... York Botanical Garden, the City University of New York, ...
... PA, July 20, 2012 A new program that trains ... they can evaluate patients with chest pain, and expedite treatment ... infarction (STEMI), a serious form of heart attack, has excellent ... two studies published in the current issue of the ...
Cached Biology News:
... 'Agilents GeneSpring Workgroup solution is ... managing and mining expression data in ... and is deployed in over 40 ... research organizations worldwide. GeneSpring Workgroup streamlines ...
... proteomic scale kinase profiling, quantitative measurement ... discovery research built on the flexible ... platform. These microarrays are available as ... Substrate - Peptide Microarray Service. ...
... PEP-165 is an 18 amino acid synthetic peptide whose sequences are ... is (amino to carboxy terminus): S(21) - S - M - ... - E - A - I - D - K - ... This peptide may be used for neutralization and control ...
... containing peptidomimetics built on the flexible ... platform. These microarrays are available as ... Microarray Service. Custom Probe ... customer specified. Thousands of customer specified ...
Biology Products: